Epidemiological Study to Describe Non Small Cell Lung Cancer Clinical Management Patterns in MENA. Lung-EPICLIN/ Gulf

Clinical trial NCT01562665 · COMPLETED

Trial details

NCT number: NCT01562665
Sponsor: AstraZeneca
Status: COMPLETED
Study type: OBSERVATIONAL

Non Small Cells Lung Cancer

Start date: 2012-06-01
Primary completion: 2015-02-01
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.